Rasagiline
- Product NDC
- 0093-3060
- 11-digit product format
- 000933060
- Labeler code
- 0093
- Product ID
- 0093-3060_c26cc45d-41aa-456c-8b37-49420366d1f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rasagiline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- NDA021641
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2017-01-03
- Substance
- RASAGILINE MESYLATE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rasagiline
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RASAGILINE MESYLATE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LH8C2JI290 |
| Rxcui | 608328, 636664 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-3060-56 | Rasagiline | 30 in 1 BOTTLE | TABLET | 30 | | 17 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-3060 | RASAGILINE TABLET [TEVA PHARMACEUTICALS USA, INC.] | 16 | Current NDC, Legacy NDC, 1 package rows | 20240927_e802c83c-e581-4a11-b83d-1df47120078d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-3060-56 | 00093306056 | 30 TABLET in 1 BOTTLE (0093-3060-56) | 30 tablet | 2017-01-03 | 0000-00-00 | No | No | Current |